Abstract
A growing number of studies have suggested that androgen in women with polycystic ovary syndrome (PCOS) exists a significant impact on the development of non-alcoholic fatty liver disease (NAFLD). We should pay more attention to the metabolism and function of androgens in PCOS women, as well as the effect and mechanism of androgens on NAFLD progression in PCOS women. This article briefly reviews and comments on this issue. Key words: Polycystic ovary syndrome; Androgens; Insulin resistance; Inflammation; Non-alcoholic fatty liver disease
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
